Calyxt, Inc. (CLXT)

$6.3

+0.33 (+5.53%)
Rating:
Recommendation:
Buy
Symbol CLXT
Price $6.3
Beta 2.043
Volume Avg. 0.02M
Market Cap 31.334M
Shares () -
52 Week Range 6.01-38.85
1y Target Est -
DCF Unlevered CLXT DCF ->
DCF Levered CLXT LDCF ->
ROE -150.26% Strong Sell
ROA -60.19% Strong Sell
Operating Margin -
Debt / Equity 537.76% Strong Buy
P/E -1.64 Sell
P/B 11.67 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest CLXT news


Mr. Michael Allen Carr
Consumer Defensive
Packaged Foods
NASDAQ Global Market

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.